Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
2(67%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(2)

Detailed Status

Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

terminated267%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
terminated

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

NCT04431544
terminated

AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)

NCT03893331
completednot_applicable

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation

NCT02825992

Clinical Trials (3)

Showing 3 of 3 trials
NCT04431544

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

Terminated
NCT03893331

AcQMap® Global Registry of Procedural and Long-term Clinical Outcomes (AcQMap Registry)

Terminated
NCT02825992Not Applicable

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3